These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15324885)
1. Exploring QSAR with E-state index: selectivity requirements for COX-2 versus COX-1 binding of terphenyl methyl sulfones and sulfonamides. Chakraborty S; Sengupta C; Roy K Bioorg Med Chem Lett; 2004 Sep; 14(18):4665-70. PubMed ID: 15324885 [TBL] [Abstract][Full Text] [Related]
2. Comparative QSAR modeling of COX-2 inhibitor 1,2-diarylimidazoles using E-state and physicochemical parameters. Chakraborty S; Sengupta C; Roy K Indian J Biochem Biophys; 2007 Jun; 44(3):169-75. PubMed ID: 17650586 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011 [TBL] [Abstract][Full Text] [Related]
4. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. Li JJ; Norton MB; Reinhard EJ; Anderson GD; Gregory SA; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Zhang Y; Zweifel BS; Reitz DB J Med Chem; 1996 Apr; 39(9):1846-56. PubMed ID: 8627608 [TBL] [Abstract][Full Text] [Related]
5. QSAR studies on structurally similar 2-(4-methanesulfonylphenyl)pyran-4-ones as selective COX-2 inhibitors: a Hansch approach. Prasanna S; Manivannan E; Chaturvedi SC Bioorg Med Chem Lett; 2005 Jan; 15(2):313-20. PubMed ID: 15603946 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors. Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002 [TBL] [Abstract][Full Text] [Related]
7. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site? Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship studies of 3,4,6-triphenylpyran-2-ones as selective cyclooxygenase-2 inhibitors. Rao PN; Uddin MJ; Knaus EE J Med Chem; 2004 Jul; 47(16):3972-90. PubMed ID: 15267236 [TBL] [Abstract][Full Text] [Related]
9. Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor. Zarghi A; Praveen Rao PN; Knaus EE Bioorg Med Chem Lett; 2004 Apr; 14(8):1957-60. PubMed ID: 15050636 [TBL] [Abstract][Full Text] [Related]
10. A CoMFA study of COX-2 inhibitors with receptor based alignment. Datar PA; Coutinho EC J Mol Graph Model; 2004 Dec; 23(3):239-51. PubMed ID: 15530820 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 3,4-diphenyl-1,2,5-oxadiazole-2-oxides and 3,4-diphenyl-1,2,5-oxadiazoles as potential hybrid COX-2 inhibitor/nitric oxide donor agents. Velázquez C; Rao PN; McDonald R; Knaus EE Bioorg Med Chem; 2005 Apr; 13(8):2749-57. PubMed ID: 15781386 [TBL] [Abstract][Full Text] [Related]
12. QSAR analyses of conformationally restricted 1,5-diaryl pyrazoles as selective COX-2 inhibitors: application of connection table representation of ligands. Prasanna S; Manivannan E; Chaturvedi SC Bioorg Med Chem Lett; 2005 Apr; 15(8):2097-102. PubMed ID: 15808476 [TBL] [Abstract][Full Text] [Related]
14. Interactions of some PGHS-2 selective inhibitors with the PGHS-1: an automated docking study by BioDock. Pedretti A; Villa AM; Villa L; Vistoli G Farmaco; 1997; 52(6-7):487-91. PubMed ID: 9372601 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of N-acetyl-2-carboxybenzenesulfonamides: a novel class of cyclooxygenase-2 (COX-2) inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Apr; 13(7):2459-68. PubMed ID: 15755648 [TBL] [Abstract][Full Text] [Related]
16. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. Mukherjee S; Saha A; Roy K Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of linear phenylethynylbenzenesulfonamide regioisomers as cyclooxygenase-1/-2 (COX-1/-2) inhibitors. Anana R; Rao PN; Chen QH; Knaus EE Bioorg Med Chem; 2006 Aug; 14(15):5259-65. PubMed ID: 16635574 [TBL] [Abstract][Full Text] [Related]
18. Exploring selectivity requirements for COX-2 versus COX-1 binding of 3,4-diaryloxazolones using E-state index. Roy K; Chakraborty S; Saha A Bioorg Med Chem Lett; 2003 Nov; 13(21):3753-7. PubMed ID: 14552773 [TBL] [Abstract][Full Text] [Related]
19. Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors. Singh SK; Vobbalareddy S; Shivaramakrishna S; Krishnamraju A; Rajjak SA; Casturi SR; Akhila V; Rao YK Bioorg Med Chem Lett; 2004 Apr; 14(7):1683-8. PubMed ID: 15026050 [TBL] [Abstract][Full Text] [Related]
20. Exploring selectivity requirements for COX-2 versus COX-1 binding of 2-(5-phenyl-pyrazol-1-yl)-5-methanesulfonylpyridines using topological and physico-chemical parameters. Chakraborty S; Sengupta C; Roy K Indian J Biochem Biophys; 2005 Apr; 42(2):106-12. PubMed ID: 23923570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]